• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Novel Effective Therapeutic Regimen for Recurrent/Metastatic Head and Neck Squamous Cell Cancer: Concurrent Triple Oral Metronomic Chemotherapy and Immunotherapy.

作者信息

Limaye Sewanti, Menon Mohan, Singh Shambhavi, Kataria Pritam, Shreenivas Aditya V, Datar Rajan, Patil Darshana, Kumar Prashant, Shah Niyati, Sheth Hardik, Sneha Suku, Madre Chetan, Deshpande Ruturaj, Menon Narayan K, Dandekar Prasad, Haribhakti Vijay

机构信息

Department of Precision Oncology, Sir H N Reliance Foundation Hospital and Research Centre, Mumbai, India.

Department of Medical Oncology, Sir H N Reliance Foundation Hospital and Research Centre, Mumbai, India.

出版信息

J Immunother Precis Oncol. 2024 Aug 19;7(3):171-177. doi: 10.36401/JIPO-24-1. eCollection 2024 Aug.

DOI:10.36401/JIPO-24-1
PMID:39220001
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11361342/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0095/11361342/92b86b989de9/i2590-017X-7-3-171-f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0095/11361342/92b86b989de9/i2590-017X-7-3-171-f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0095/11361342/92b86b989de9/i2590-017X-7-3-171-f01.jpg

相似文献

1
Novel Effective Therapeutic Regimen for Recurrent/Metastatic Head and Neck Squamous Cell Cancer: Concurrent Triple Oral Metronomic Chemotherapy and Immunotherapy.复发性/转移性头颈部鳞状细胞癌的新型有效治疗方案：三联口服节拍化疗与免疫治疗同步进行
J Immunother Precis Oncol. 2024 Aug 19;7(3):171-177. doi: 10.36401/JIPO-24-1. eCollection 2024 Aug.
2
Metronomic palliative chemotherapy in locally advanced, recurrent and metastatic head-and-neck cancer: A single-arm, retrospective study of a regional cancer center of North India (Asia).节拍式姑息化疗用于局部晚期、复发和转移性头颈癌：印度北部（亚洲）某地区癌症中心的单臂回顾性研究
J Cancer Res Ther. 2020 Apr-Jun;16(3):559-564. doi: 10.4103/jcrt.JCRT_702_18.
3
Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial.低剂量口服节拍化疗与静脉注射顺铂治疗复发性、转移性、不可手术的头颈部鳞癌患者的疗效比较：一项开放标签、平行组、非劣效性、随机、3 期临床试验。
Lancet Glob Health. 2020 Sep;8(9):e1213-e1222. doi: 10.1016/S2214-109X(20)30275-8.
4
Initial analysis of the synergy of programmed cell death-1 (PD-1) inhibitor and concurrent chemoradiotherapy treatment for recurrent/metastatic head and neck squamous cell carcinoma patients.程序性细胞死亡受体 1（PD-1）抑制剂联合同期放化疗治疗复发性/转移性头颈部鳞状细胞癌患者的协同作用的初步分析。
Radiat Oncol. 2023 Jul 4;18(1):109. doi: 10.1186/s13014-023-02310-8.
5
Beyond conventional chemotherapy, targeted therapy and immunotherapy in squamous cell cancer of the oral cavity.超越常规化疗的口腔鳞癌的靶向治疗和免疫治疗。
Oral Oncol. 2020 Jun;105:104673. doi: 10.1016/j.oraloncology.2020.104673. Epub 2020 Apr 6.
6
Capecitabine metronomic chemotherapy combined with autologous CIK cell immunotherapy in the treatment of recurrent and metastatic triple-negative breast cancer.卡培他滨节拍化疗联合自体 CIK 细胞免疫治疗复发性转移性三阴性乳腺癌。
J BUON. 2021 May-Jun;26(3):734-740.
7
Oral Metronomic Chemotherapy in Advanced and Metastatic Oral Squamous Cell Carcinoma: A Need of the Hour.晚期和转移性口腔鳞状细胞癌的口服节拍化疗：当务之急
J Maxillofac Oral Surg. 2024 Aug;23(4):793-800. doi: 10.1007/s12663-023-01963-y. Epub 2023 Jul 4.
8
Immunotherapy in Patients with Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck.免疫疗法在复发性和转移性头颈部鳞状细胞癌患者中的应用。
Anticancer Agents Med Chem. 2019;19(3):290-303. doi: 10.2174/1871520618666180910092356.
9
Chemotherapy and immunotherapy for recurrent and metastatic head and neck cancer: a systematic review.复发性和转移性头颈部癌症的化疗和免疫治疗：系统评价。
Med Oncol. 2018 Feb 13;35(3):37. doi: 10.1007/s12032-018-1096-5.
10
Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial.丙戊酸联合顺铂和西妥昔单抗治疗复发和/或转移性头颈部鳞状细胞癌的II期临床研究-V-CHANCE试验
BMC Cancer. 2016 Nov 25;16(1):918. doi: 10.1186/s12885-016-2957-y.

本文引用的文献

1
Chemo-Immunotherapy: A New Trend in Cancer Treatment.化学免疫疗法：癌症治疗的新趋势。
Cancers (Basel). 2023 May 25;15(11):2912. doi: 10.3390/cancers15112912.
2
Metronomic Chemotherapy: Anti-Tumor Pathways and Combination with Immune Checkpoint Inhibitors.节拍化疗：抗肿瘤途径及与免疫检查点抑制剂的联合应用
Cancers (Basel). 2023 Apr 26;15(9):2471. doi: 10.3390/cancers15092471.
3
Retrospective analysis: checkpoint inhibitor accessibility for thoracic and head and neck cancers and factors influencing it in a tertiary centre in India.
回顾性分析：印度一家三级中心中胸癌和头颈癌患者使用检查点抑制剂的可及性及其影响因素
Ecancermedicalscience. 2022 Nov 3;16:1464. doi: 10.3332/ecancer.2022.1464. eCollection 2022.
4
Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers: ASCO Guideline.免疫治疗和生物标志物检测在复发性和转移性头颈部癌症中的应用：ASCO 指南。
J Clin Oncol. 2023 Feb 10;41(5):1132-1146. doi: 10.1200/JCO.22.02328. Epub 2022 Dec 15.
5
Cost Savings and Increased Access With Ultra-Low-Dose Immunotherapy.超低剂量免疫疗法可节省成本并增加可及性。
J Clin Oncol. 2023 Jan 10;41(2):170-172. doi: 10.1200/JCO.22.01711. Epub 2022 Oct 20.
6
Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study.头颈部癌的低剂量免疫疗法：一项随机研究。
J Clin Oncol. 2023 Jan 10;41(2):222-232. doi: 10.1200/JCO.22.01015. Epub 2022 Oct 20.
7
Improving access to immunotherapy in low- and middle-income countries.改善低收入和中等收入国家获得免疫疗法的机会。
Ann Oncol. 2022 Apr;33(4):360-361. doi: 10.1016/j.annonc.2022.01.003. Epub 2022 Jan 13.
8
Role of metronomic therapy for advanced oral cancers and predictors of response: Multi-institutional feasibility study.节拍化疗在晚期口腔癌中的作用及反应预测因素：多机构可行性研究。
Head Neck. 2022 Jan;44(1):104-112. doi: 10.1002/hed.26904. Epub 2021 Oct 28.
9
Metronomic Therapy in Oral Squamous Cell Carcinoma.口腔鳞状细胞癌的节拍式化疗
J Clin Med. 2021 Jun 26;10(13):2818. doi: 10.3390/jcm10132818.
10
Oral metronomic therapy in head and neck cancer - Authors' reply.头颈部癌的口服节拍器疗法——作者回复
Lancet Glob Health. 2021 Jan;9(1):e21. doi: 10.1016/S2214-109X(20)30471-X.